KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (KALV)

CUSIP: 483497103

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+1,235,072
Put/Call ratio
121%
SEC-reported price per share
$11.78
Number of holders
118
Value change
+$14,329,598
Number of buys
62
Open additional details 1 more signal available
Number of sells
59
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
53,230,928

Security key

483497103

Report period

Q2 2024

Institutions

118

Top holders

10

Ownership snapshot

Top reported holders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Venrock Adviser, LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership Top 5
Venrock Adviser, LLC 12%
SUVRETTA CAPITAL MANAGEMENT, LLC 7.9%
TANG CAPITAL MANAGEMENT LLC 7.7%
Frazier Life Sciences Management,... 6.9%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Venrock Adviser, LLC
13F
Company
13F
12%
$74,121,810
6,249,731 shares
31 Mar 2024
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
7.9%
$49,717,179
4,192,005 shares
31 Mar 2024
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
7.7%
$48,926,592
4,125,345 shares
31 Mar 2024
Frazier Life Sciences Management, L.P.
13F
Company
13F
6.9%
$43,738,103
3,687,867 shares
31 Mar 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
4.8%
$30,539,500
2,575,000 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
4.6%
$28,846,295
2,432,234 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
118
Shares
48,235,227
Rows available
118
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
128
Q2 2024 holders
118
Holder diff
-10
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .